<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have analyzed the distribution of terminal deoxynucleotidyl transferase (TdT) in 30 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), in connection with <z:mp ids='MP_0000002'>morphology</z:mp>, cytochemistry, and cytogenetics </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> cases in preleukemic phase were strictly TdT-negative </plain></SENT>
<SENT sid="2" pm="."><plain>At variance, 4 (19%) of 21 cases with subsequent <z:hpo ids='HP_0001909'>leukemia</z:hpo> were TdT-positive and showed a pure lymphoid (one case) or a mixed lymphoid-myelomonocytic (three cases) <z:mp ids='MP_0000002'>morphology</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The TdT enzymatic activity ranged from 2 to 21 U/10(8) cells and the percent of positive cells in the immunofluorescence test ranged from 10 to 80% of total </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> cases were Philadelphia chromosome-negative </plain></SENT>
<SENT sid="5" pm="."><plain>The clonal origin of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> from the pluripotent stem cell, capable of originating both a lymphoid and myeloid progeny, is further corroborated </plain></SENT>
</text></document>